BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 38656402)

  • 1. Delivery of lipophilic bioactives: assembly, disassembly, and reassembly of lipid nanoparticles.
    Yao M; Xiao H; McClements DJ
    Annu Rev Food Sci Technol; 2014; 5():53-81. PubMed ID: 24328432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wheat germ agglutinin modified mixed micelles overcome the dual barrier of mucus/enterocytes for effective oral absorption of shikonin and gefitinib.
    Hou X; Ai X; Liu Z; Yang J; Wu Y; Zhang D; Feng N
    Drug Deliv Transl Res; 2024 Apr; ():. PubMed ID: 38656402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination of shikonin and gefitinib reverses drug resistance in human non-small cell lung cancer and its mechanism].
    Ai XY; Hou XF; Feng NP
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):175-184. PubMed ID: 38403350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal transfer of wheat germ agglutinin modified lipid-polymer hybrid nanoparticles for oral delivery of oridonin.
    Liu Y; Liu J; Liang J; Zhang M; Li Z; Wang Z; Dang B; Feng N
    Nanomedicine; 2017 Oct; 13(7):2219-2229. PubMed ID: 28539275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting oral absorption of Panax notoginseng saponins via thiolated trimethyl chitosan and wheat germ agglutinin-modified nanoformulation.
    Fang R; Zhao Y; Lin S; Wei Y; Chen H
    Drug Deliv Transl Res; 2024 Mar; 14(3):621-636. PubMed ID: 37787882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
    Liu Y; Xie X; Hou X; Shen J; Shi J; Chen H; He Y; Wang Z; Feng N
    J Nanobiotechnology; 2020 May; 18(1):83. PubMed ID: 32473632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly oxidized germacranolide from elephantopus tomentosus inhibits the growth of hepatocellular carcinoma cells by targeting EGFR in vitro and in vivo.
    Li Q; Niu JQ; Jia JH; Xu W; Bai M; Yao GD; Song SJ
    Bioorg Chem; 2024 Feb; 143():107007. PubMed ID: 38039928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block Copolymer Encapsulation of Disarib, an Inhibitor of BCL2 for Improved Chemotherapeutic Potential.
    Joy R; Siddiqua H; Sharma S; Raveendran M; John F; Hassan PA; Gawali SL; Raghavan SC; George J
    ACS Omega; 2023 Oct; 8(43):40729-40740. PubMed ID: 37929147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway.
    Wang D; Jiang Q; Dong Z; Meng T; Hu F; Wang J; Yuan H
    Adv Drug Deliv Rev; 2023 Dec; 203():115130. PubMed ID: 37913890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Charged Block Length Mismatch on Double Diblock Polyelectrolyte Complex Micelle Cores.
    Stevens KC; Marras AE; Campagna TR; Ting JM; Tirrell MV
    Macromolecules; 2023 Jul; 56(14):5557-5566. PubMed ID: 37521249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular energy production and distribution in hypoxia.
    Flood D; Lee ES; Taylor CT
    J Biol Chem; 2023 Sep; 299(9):105103. PubMed ID: 37507013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Nanoparticle Transport across Intestinal Tissue: An Oral Delivery Perspective.
    Ejazi SA; Louisthelmy R; Maisel K
    ACS Nano; 2023 Jul; 17(14):13044-13061. PubMed ID: 37410891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native gastrointestinal mucus: Critical features and techniques for studying interactions with drugs, drug carriers, and bacteria.
    Wang CM; Fernez MT; Woolston BM; Carrier RL
    Adv Drug Deliv Rev; 2023 Sep; 200():114966. PubMed ID: 37329985
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.